CCEL
Cryo-Cell International Inc (CCEL)
Healthcare • NYSE MKT • $3.45-3.54%
- Symbol
- CCEL
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Price
- $3.45
- Daily Change
- -3.54%
- Market Cap
- $27.82M
- Trailing P/E
- N/A
- Forward P/E
- 172.66
- 52W High
- $6.35
- 52W Low
- $2.72
- Analyst Target
- N/A
- Dividend Yield
- +17.38%
- Beta
- 0.58
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, chi…
Company websiteResearch CCEL on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.